172@29@16@17!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=0&is_responsive=1&sec=PNC_FINANCIAL&priceinter=1&frommc=1!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_header.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
you are here:

Brooks Laboratories Ltd.

BSE: 533543 | NSE: BROOKS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE650L01011 | SECTOR: Pharmaceuticals

BSE Live

Sep 24, 16:00
59.55 2.80 (4.93%)
Volume
AVERAGE VOLUME
5-Day
18,560
10-Day
11,724
30-Day
9,506
35,566
  • Prev. Close

    56.75

  • Open Price

    58.35

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Sep 24, 15:41
59.30 2.80 (4.96%)
Volume
AVERAGE VOLUME
5-Day
75,048
10-Day
53,735
30-Day
43,484
73,769
  • Prev. Close

    56.50

  • Open Price

    58.30

  • Bid Price (Qty.)

    59.30 (29910)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2019 2018 2017 2016 2015
Balance Sheet of Brooks Laboratories (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
EQUITIES AND LIABILITIES  
SHAREHOLDER'S FUNDS  
Equity Share Capital 24.70 16.19 16.19 16.19 16.19  
Total Share Capital 24.70 16.19 16.19 16.19 16.19  
Reserves and Surplus 73.71 83.41 98.29 112.09 105.86  
Total Reserves and Surplus 73.71 83.41 98.29 112.09 105.86  
Total Shareholders Funds 98.42 105.15 114.47 128.28 122.05  
NON-CURRENT LIABILITIES  
Long Term Borrowings 11.40 13.86 16.63 10.73 0.34  
Deferred Tax Liabilities [Net] 0.00 0.00 0.00 0.00 1.46  
Other Long Term Liabilities 0.53 0.00 0.00 0.00 0.00  
Long Term Provisions 1.72 1.48 1.08 0.87 0.76  
Total Non-Current Liabilities 13.65 15.34 17.71 11.59 2.57  
CURRENT LIABILITIES  
Short Term Borrowings 12.61 14.47 8.54 2.18 5.28  
Trade Payables 26.07 27.14 26.65 18.36 15.92  
Other Current Liabilities 6.56 5.64 4.95 3.60 5.41  
Short Term Provisions 0.56 0.22 0.35 0.13 1.31  
Total Current Liabilities 45.80 47.46 40.48 24.26 27.92  
Total Capital And Liabilities 157.86 167.95 172.67 164.13 152.54  
ASSETS  
NON-CURRENT ASSETS  
Tangible Assets 113.13 117.17 124.01 125.31 16.34  
Intangible Assets 0.00 0.08 0.00 0.00 0.00  
Capital Work-In-Progress 0.00 0.00 0.52 0.00 87.09  
Other Assets 0.00 0.63 0.63 0.63 0.00  
Fixed Assets 113.13 118.17 125.17 125.95 103.42  
Non-Current Investments 0.02 0.02 0.02 0.02 0.02  
Deferred Tax Assets [Net] 0.00 10.91 10.74 6.99 0.00  
Long Term Loans And Advances 0.00 0.00 0.00 0.00 16.56  
Other Non-Current Assets 6.79 6.88 6.05 9.30 0.00  
Total Non-Current Assets 119.95 135.99 141.97 142.26 120.01  
CURRENT ASSETS  
Current Investments 0.00 0.00 0.00 0.00 0.00  
Inventories 13.77 10.05 11.41 7.70 6.69  
Trade Receivables 15.56 11.42 10.18 10.69 18.91  
Cash And Cash Equivalents 1.53 3.47 1.96 1.84 2.23  
Short Term Loans And Advances 0.00 0.00 0.00 0.02 4.48  
OtherCurrentAssets 7.05 7.02 7.14 1.62 0.22  
Total Current Assets 37.92 31.96 30.69 21.87 32.53  
Total Assets 157.86 167.95 172.67 164.13 152.54  
OTHER ADDITIONAL INFORMATION  
CONTINGENT LIABILITIES, COMMITMENTS  
Contingent Liabilities 0.00 25.90 24.77 20.38 35.25  
CIF VALUE OF IMPORTS  
Raw Materials 0.00 0.00 0.00 0.00 2.94  
Stores, Spares And Loose Tools 0.00 0.00 0.00 0.00 0.00  
Trade/Other Goods 0.00 0.00 0.00 0.00 0.00  
Capital Goods 0.00 0.00 0.00 0.00 0.64  
EXPENDITURE IN FOREIGN EXCHANGE  
Expenditure In Foreign Currency 0.00 0.00 0.00 0.00 0.01  
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS  
Dividend Remittance In Foreign Currency -- -- -- -- --  
EARNINGS IN FOREIGN EXCHANGE  
FOB Value Of Goods -- -- -- -- --  
Other Earnings -- -- -- -- --  
BONUS DETAILS  
Bonus Equity Share Capital -- 9.12 9.12 9.12 9.12  
NON-CURRENT INVESTMENTS  
Non-Current Investments Quoted Market Value -- -- -- -- --  
Non-Current Investments Unquoted Book Value -- 0.02 0.02 0.02 0.02  
CURRENT INVESTMENTS  
Current Investments Quoted Market Value -- -- -- -- --  
Current Investments Unquoted Book Value -- -- -- -- --  
Source : Dion Global Solutions Limited